Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
190.66
0.00 (0.00%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Danaher Employees
Danaher had 63,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
63,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$378,968
Profits / Employee
$61,889
Market Cap
133.67B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63,000 | 0 | - |
Dec 31, 2023 | 63,000 | -18,000 | -22.22% |
Dec 31, 2022 | 81,000 | 1,000 | 1.25% |
Dec 31, 2021 | 80,000 | 11,000 | 15.94% |
Dec 31, 2020 | 69,000 | 9,000 | 15.00% |
Dec 31, 2019 | 60,000 | -11,000 | -15.49% |
Dec 31, 2018 | 71,000 | 4,000 | 5.97% |
Dec 31, 2017 | 67,000 | 5,000 | 8.06% |
Dec 31, 2016 | 62,000 | -19,000 | -23.46% |
Dec 31, 2015 | 81,000 | 10,000 | 14.08% |
Dec 31, 2014 | 71,000 | 5,000 | 7.58% |
Dec 31, 2013 | 66,000 | 3,000 | 4.76% |
Dec 31, 2012 | 63,000 | 4,000 | 6.78% |
Dec 31, 2011 | 59,000 | 10,800 | 22.41% |
Dec 31, 2010 | 48,200 | 1,600 | 3.43% |
Dec 31, 2009 | 46,600 | -3,700 | -7.36% |
Dec 31, 2008 | 50,300 | 300 | 0.60% |
Dec 31, 2007 | 50,000 | 5,000 | 11.11% |
Dec 31, 2006 | 45,000 | 5,000 | 12.50% |
Dec 31, 2005 | 40,000 | 5,000 | 14.29% |
Dec 31, 2004 | 35,000 | 5,000 | 16.67% |
Dec 31, 2003 | 30,000 | 1,000 | 3.45% |
Dec 31, 2002 | 29,000 | 6,000 | 26.09% |
Dec 31, 2001 | 23,000 | -1,000 | -4.17% |
Dec 31, 2000 | 24,000 | 5,000 | 26.32% |
Dec 31, 1999 | 19,000 | 1,000 | 5.56% |
Dec 31, 1998 | 18,000 | 4,800 | 36.36% |
Dec 31, 1997 | 13,200 | 1,600 | 13.79% |
Dec 31, 1996 | 11,600 | 1,100 | 10.48% |
Dec 31, 1995 | 10,500 | 540 | 5.42% |
Dec 31, 1994 | 9,960 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
DHR News
- 16 days ago - 3 Wide-Moat Dividend Stars For A Championship Portfolio - Seeking Alpha
- 18 days ago - Danaher Corporation: A Mixed Bag Of Strength And Stagnation - Seeking Alpha
- 18 days ago - Danaher: Some Near-Term Headwinds, But Good Long-Term Prospects And Low Valuations - Seeking Alpha
- 25 days ago - 8 Upcoming Dividend Increases, Including A King - Seeking Alpha
- 27 days ago - Danaher: Near 5-Year Low Is A Great Entry Point - Seeking Alpha
- 4 weeks ago - Danaher Schedules First Quarter 2025 Earnings Conference Call - PRNewsWire
- 5 weeks ago - Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System - PRNewsWire
- 6 weeks ago - Danaher Corporation (DHR) TD Cowen 45th Annual Health Care Conference Transcript - Seeking Alpha